BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
34.17
-0.68 (-1.95%)
At close: May 9, 2025, 4:00 PM
35.48
+1.31 (3.83%)
After-hours: May 9, 2025, 5:10 PM EDT

BridgeBio Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-667.97-535.76-643.2-481.18-562.54-448.72
Upgrade
Depreciation & Amortization
5.766.086.496.775.841.46
Upgrade
Loss (Gain) From Sale of Assets
-178.32-178.321.246.26--
Upgrade
Asset Writedown & Restructuring Costs
0.270.27-12.72-4.73
Upgrade
Loss (Gain) From Sale of Investments
--8.14-18.318.22-29.91-
Upgrade
Loss (Gain) on Equity Investments
46.7431.18----
Upgrade
Stock-Based Compensation
104.6395.8108.7191.5699.5158.46
Upgrade
Other Operating Activities
47.3936.1212.29-91.92-6.43-30.57
Upgrade
Change in Accounts Receivable
120.23-2.9715.3315.17-19.75-
Upgrade
Change in Accounts Payable
25.011.512.78-0.352.83-0.74
Upgrade
Change in Unearned Revenue
-4.7221.88-5.4415.26--
Upgrade
Change in Other Net Operating Assets
3.7511.63-7.61-212.5215.67
Upgrade
Operating Cash Flow
-500.42-520.73-527.72-419.49-497.93-399.71
Upgrade
Capital Expenditures
-0.24-0.93-1.31-4.82-13.25-7.52
Upgrade
Sale of Property, Plant & Equipment
---10--
Upgrade
Cash Acquisitions
----13.65-
Upgrade
Divestitures
-0.14-0.14-0.5---
Upgrade
Sale (Purchase) of Intangibles
-8.77-7.98--1.5-35-
Upgrade
Investment in Securities
45.5844.1555.84339.47-166.23-38.72
Upgrade
Other Investing Activities
-25.68-110--6.76
Upgrade
Investing Cash Flow
36.4360.7854.03453.15-200.83-52.99
Upgrade
Long-Term Debt Issued
-950--1,204550
Upgrade
Long-Term Debt Repaid
--473.42--20.49-124.12-
Upgrade
Net Debt Issued (Repaid)
616476.58--20.491,080550
Upgrade
Issuance of Common Stock
10.5322.9459.228.0820.4614.13
Upgrade
Repurchase of Common Stock
-54.64-7.53-6.88-1.56-204.75-75.71
Upgrade
Other Financing Activities
-42.62-43.5-0.80.84-158.95-41.23
Upgrade
Financing Cash Flow
529.24748.46451.54-13.13736.45447.19
Upgrade
Net Cash Flow
65.25288.51-22.1520.5237.69-5.52
Upgrade
Free Cash Flow
-500.66-521.66-529.03-424.32-511.18-407.23
Upgrade
Free Cash Flow Margin
-392.94%-235.08%-5686.62%-546.46%-733.23%-4936.74%
Upgrade
Free Cash Flow Per Share
-2.65-2.80-3.25-2.88-3.54-3.45
Upgrade
Cash Interest Paid
79.391.3461.1154.4429.7715.32
Upgrade
Levered Free Cash Flow
-261.2-288.27-249.07-285.88-301.13-250.16
Upgrade
Unlevered Free Cash Flow
-187.48-226.21-198.26-235.61-271.89-227.25
Upgrade
Change in Net Working Capital
-119.12-13.3-56.1937.11-23.27-16.91
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q